Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy

Clinical trial NCT00004939 · COMPLETED

Trial details

NCT number

NCT00004939

Sponsor

National Center for Research Resources (NCRR)

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

1996-08-01

Enrollment

34

View on ClinicalTrials.gov